Outside the system

Discharged: How Palantir’s £330 Million NHS Contract Got the Chop

The UK Government’s decision is a breakthrough in a long-running battle over public data, corporate power and democratic accountability, reports Iain Overton

NHS staff blockade the entrance to NHS England's headquarters in central London demanding the cancellation of its contract with Palantir, 3 April 2024. Photo: PA Images

Read Our Monthly Magazine

And support our mission to provide fearless stories about and outside the media system

The British Government has confirmed that Palantir’s controversial £330 million NHS contract will end in March 2029. It brings a promised – albeit delayed – conclusion to a contract that, for years, has raised major questions about undue corporate influence, patient privacy and the outsourcing of British public infrastructure all to a controversial American technology company.

Labour Health minister James Frith told Parliament on 16 November the Government would begin procuring a replacement for the NHS Federated Data Platform (FDP). The Government would, he said, retain the existing contract for a further two years to protect continuity of care.

It’s an announcement that has been a long time coming.

Since 2021, this publication has been investigating Palantir’s expanding presence across British public services. We have documented the company’s Government contracts and traced its growing relationship with NHS decision-makers. And throughout we have raised major questions surrounding Peter Thiel’s company’s access to some of Britain’s most sensitive public infrastructure.

What began as a scrutiny of an emergency pandemic-era arrangement with the US tech firm has developed into a much broader debate into how a company with such deep roots in American intelligence and defence has been able to position itself at the heart of the British jewel that is the NHS.

Our reporting began in February 2021 when David Hencke wrote about a legal challenge to Palantir’s £23 million NHS contract. This, we reported, was awarded without an open competitive tender during the pandemic. We questioned whether the public had been adequately consulted and whether safeguards governing sensitive health information were sufficient.

A month later, Byline Times reported that the Government had made concessions, agreeing not to expand the company’s NHS datastore work beyond its pandemic purposes without further public notification and data-protection assessments.

EXCLUSIVE

Palantir Co-Founder Peter Thiel and Reform UK’s Cambridge University Recruitment Pipeline Project Revealed

The world-renowned academic institution has nothing to say in response to a six-month investigation by Byline Times raising serious concerns about the safeguarding of students and foreign influence at Cambridge University. Why?

Nafeez Ahmed

and

Peter Jukes

But, by then, the company’s ambitions were already extending far beyond COVID-19.

In July 2021, Byline Times journalist Max Colbert, in league with the campaigning group The Citizens, mapped more than £100 million in Government contracts involving Palantir and British AI company Faculty. His reporting detailed approximately £24.9 million of contracts connected to the NHS and Department of Health and Social Care.

We mapped the sheer scale of the companies’ involvement right across Government, from healthcare to defence to intelligence and, by June 2022, in the piece How the Tentacles of Palantir Continue to Encircle the NHS, we were to examine how the company was positioning itself for the forthcoming Federated Data Platform (FDP) contract. 

Again, the central question was whether a temporary emergency supplier was becoming a permanent fixture in Britain’s healthcare system. 

In November 2023, Palantir was awarded the FDP contract, worth up to £330 million.

The cracks in this relationship, however, began to be seen. By July 2026, we reported growing opposition from local authorities, including Sheffield and Rotherham, as concerns over digital sovereignty, transparency and public confidence in Palantir intensified.

Alongside this, Byline Times also investigated the political relationships that helped Palantir consolidate such a position across the British state. 

In June 2026, Peter Jukes exposed how former British ambassador Peter Mandelson helped facilitate the company’s expanding relationship with Government. He showed how, despite retaining a financial interest in Global Counsel, a lobbying firm that counted Palantir among its clients, the now-disgraced former minister Mandelson had arranged for Prime Minister Keir Starmer’s to visit Palantir’s Washington headquarters in February 2025.  

Jukes also detailed how Mandelson subsequently involved himself in preparations for a defence agreement announced during Donald Trump’s September state visit. That agreement led to an expansion of Palantir’s Ministry of Defence contract to some £750 million over five years. 

It was to raise further questions about corporate access to Government and highlighted concerns about potential conflicts of interests.

Such concerns seemed, in the end, to reach the floor of the House of Commons on Monday.

Liberal Democrat spokesperson Helen Morgan argued that the NHS contract had been surrounded by secrecy from the start and called for Palantir to be removed from the healthcare system entirely. Other MPs critiqued the company’s performance claims and the raised possibility that the health service had become dependent on its proprietary technology. One described Palantir as an “albatross” around the NHS’s neck.

ENJOYING THIS ARTICLE? HELP US TO PRODUCE MORE

Receive the monthly Byline Times newspaper and help to support fearless, independent journalism that breaks stories, shapes the agenda and holds power to account.

We’re not funded by a billionaire oligarch or an offshore hedge-fund. We rely on our readers to fund our journalism. If you like what we do, please subscribe.

Dr Alison Gardner MP also questioned claims that the platform had helped deliver more than 110,000 additional operations, saying that the headline improvements were concentrated in relatively few NHS Trusts.

The health minister acknowledged that any exaggerated claims of benefits should, indeed, be corrected and went on to promise scrutiny of the platform’s performance.

What he did not do, however, was announce an immediate termination.

Frith confirmed that the current arrangement with Palantir would continue until March 2029 while a new procurement process was undertaken. The Government insists this time lag is needed in order to avoid disruption to services already reliant on that platform.

Such ‘capture’ is not unheard of. Technological dependence of the Government to Palantir’s technology has already been evident at the Ministry of Defence, which had to justify awarding Palantir a £240.6 million contract without competition by acknowledging that its existing data architecture could only be supported by Palantir itself. In effect it is a supplier lock-in that makes genuine competition increasingly difficult.

As such, the two-year transition noted by the health minister raises the most salient question: can the NHS can genuinely disentangle itself from a supplier that has already become so deeply embedded in its operations? 

The minister insisted that the NHS was not locked in and that contractual provisions would permit migration to another provider, but offered little in proof of such.

Palantir’s departure is therefore promised, but nothing is assured. 

Nonetheless, for five years, Byline Times has helped document the questions that dominated the decision. 

We have, from the start, asked: who controls NHS data? How are technology contracts awarded? And what happens when private companies risk capturing the running of public services?

The Government has, for now at least, accepted that the next generation of NHS data infrastructure must be built around competition, transparency and public trust.

Things, by insinuation, the Government seems to feel Palantir has yet to prove it can deliver on.


Written by

Iain Overton is the executive director of the Action On Armed Violence charity


This article was filed under
, , , , ,